Home » Topics » BioWorld Science, Nephrology

BioWorld Science, Nephrology
RSS

Recordati to develop silodosin for BPH in Europe

Dec. 15, 2004

Novel PDE5 inhibitor from Fujisawa

Dec. 13, 2004

Researchers at Dynogen describe a new treatment for urinary tract disorders

Dec. 7, 2004

Conivaptan increases serum sodium levels in patients with hyponatremia

Dec. 3, 2004

Approvable letter for hyponatremia drug YM-087

Dec. 3, 2004

AVE-7688 provides renal protection in diabetes model

Nov. 29, 2004

Vesicare approved by FDA

Nov. 24, 2004

Gabapentin delays ejaculation in a case of PE / News in Context

Nov. 24, 2004

Darifenacin shows efficacy in the treatment of women with overactive bladder

Nov. 19, 2004

NH3 exchange inhibitors and their use described by Aventis

Nov. 19, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 15, 2026.
ASGCT 2026: Circular RNA, the new beast in gene and cell therapy
BioWorld
Circular RNA (circRNA) is not a new concept, but it is a novel strategy in the field of gene and cell therapy. While mRNA vaccines have revolutionized medicine,...
Advancing the 'best of both' – BMS, Hengrui enter $15.2B deal
BioWorld
In a deal potentially worth up to $15.2 billion, Jiangsu Hengrui Pharmaceuticals Co. Ltd. is joining efforts with Bristol Myers Squibb Co. to advance 13 early...
ASGCT 2026: Uncovering the mechanisms of AAV toxicity
BioWorld
Gene therapies rely on vectors to reach the target tissue where they act, such as adeno-associated viruses (AAVs) or lipid nanoparticles (LNPs), among other...
Roche secures CE mark for Alzheimer’s blood test
BioWorld
Roche Holding AG secured CE marking for the Elecsys plasma phosphorylated-tau 217 blood test designed to rule in and rule out amyloid pathology, a hallmark of...